Evidence map›Paper›PMID 30115763›Full record

ReviewLearning & memory (Cold Spring Harbor, N.Y.)2018

Heterogeneous dopamine signals support distinct features of motivated actions: implications for learning and addiction.

Michael P Saddoris, Kayla A Siletti, Katherine J Stansfield, Maria Florencia Bercum

Abstract readReview
In one paragraph

Review in Learning & memory (Cold Spring Harbor, N.Y.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Michael P SaddorisDepartment of Psychology and Neuroscience, University of Colorado, Boulder, Colorado 80309, USA.ORCID 0000-0002-0491-880X
Kayla A SilettiDepartment of Psychology and Neuroscience, University of Colorado, Boulder, Colorado 80309, USA.
Katherine J StansfieldDepartment of Psychology and Neuroscience, University of Colorado, Boulder, Colorado 80309, USA.
Maria Florencia BercumDepartment of Psychology and Neuroscience, University of Colorado, Boulder, Colorado 80309, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite decades of research, investigations into effective neural and pharmacological therapies for many drugs of abuse, such as cocaine, have produced no FDA-approved approaches. This difficulty derives from the complexity of substance use disorders, which encompass a variety of behavioral, psychological, and neural circuit-based changes that occur as a result of repeated experience with the drug. Dopamine signaling has been demonstrated to play a key role in several aspects of drug abuse-from mediating its reinforcing properties and drug-seeking to triggering relapse-while also mediating a number of important aspects of normal (nondrug related) motivated behaviors and actions. Real-time recording methods such as in vivo voltammetry, electrophysiology, and calcium imaging demonstrate that the signaling properties of dopamine for motivationally relevant stimuli are highly dynamic and spatiotemporally circumscribed within afferent target regions. In this review, we identify the origins and functional consequences of heterogeneous dopamine release in the limbic system, and how these properties are persistently altered in the drug-experienced brain. We propose that these spatiotemporally parallel dopaminergic signals are simultaneously available to the animal, but that these circuits are impaired following prolonged drug experience by disrupting the location and content of dopamine signals in afferent target regions. These findings are discussed in the context of relapse and pathways to discovering new treatments for addiction disorders.

Indexed as

BrainLearningMotivationNerve NetSignal TransductionAnimalsCentral Nervous System StimulantsDopamineHumansSubstance-Related DisordersCentral Nervous System StimulantsDopamine

Identifiers

PMID30115763
PMCPMC6097772

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.